MUSCLESPORT LIPOSLIM REVOLUTION NON-STIM FAT METABOLIZER

Most of us have heard the phrases “good fats” and “bad fats”. Good fats are healthy and help burn the bad fats that result from poor diet, lack of exercise, etc… Unfortunately, the good fats are typically only found in small quantities in food. As a result, LipoSlim Revolution has isolated a great fatty acid profile to boost fat-burning capacity and overall health. Get your good fats. Get LipoSlim Revolution.

MuscleSport LipoSlim Revolution Non-Stim Fat Metabolizer Benefits:

• Amazing fatty acid profile to melt fat and improve health

• Zero caffeine or stimulants

• Includes EPA & DHA to trigger fat burning on the genetic level

• Hinders fat storage

• Activates thermogenesis & fat oxidation

• May increase protein synthesis

MuscleSport LipoSlim Revolution Non-Stim Fat Metabolizer Ingredient Breakdown:

Conjugated Linoleic Acid (CLA) -  known to reduce bodyfat, increase lean muscle mass and support metabolism. A potent anti-oxidant and immune enhancer.

EPA -  a heart healthy fat that aids in complete health

DHA -  necessary for cognitive and mental function.

ALA -  boosts overall health & well-being

Customers Love Stacking With:

MuscleSport BCAA Revolution 

MuscleSport Lean Whey Revolution 

How To Take MuscleSport LipoSlim Revolution Non-Stim Fat Metabolizer:

As a dietary supplement, take one to two servings (1- 2 softgels) up to three times daily with meals.

MuscleSport LipoSlim Revolution Non-Stim Fat Metabolizer Supplement Facts

Serving Size: 2 Capsules

Servings Per Container: 30

Vitamin B3 20mg

Vitamin B6 4.25mg

Chromium (Chromium Polynicotinate) 100mcg

Fat Annihilating Complex

Caffeine Matrix (Caffeine Anhydrous, DiCaffeine Malate, Caffeine Citrate) 375mg

Beta-Phenylethylamine 250mg

Celery Seed Extract 250mg

Hordenine 100mg

DIM (Diindolylmethane) 100mg

Phosphatidylserine 100mg

Isopropylnorsynephrine 25g

Halostachine 20mg

Synephrine 20mg

Yohimbine HCL 5mg

CapsiAtra (Dihydrocapsiate) 3mg

References:

Ebrahimi-Mameghani, Mehrangiz et al. “Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.” Croatian medical journal vol. 57,4 (2016): 331-42. doi:10.3325/cmj.2016.57.331

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048220/

Kidd, Parris M. “Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.” Alternative medicine review : a journal of clinical therapeutic vol. 12,3 (2007): 207-27.

https://pubmed.ncbi.nlm.nih.gov/18072818/

Kim, Yoo et al. “Impact of Conjugated Linoleic Acid (CLA) on Skeletal Muscle Metabolism.” Lipids vol. 51,2 (2016): 159-78. doi:10.1007/s11745-015-4115-8

https://pubmed.ncbi.nlm.nih.gov/26729488/

Patrick, Rhonda P. “Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 33,2 (2019): 1554-1564. doi:10.1096/fj.201801412R

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338661/

Saitoh, Shinichi et al. “5-aminolevulinic acid (ALA) deficiency causes impaired glucose tolerance and insulin resistance coincident with an attenuation of mitochondrial function in aged mice.” PloS one vol. 13,1 e0189593. 24 Jan. 2018, doi:10.1371/journal.pone.0189593

https://pubmed.ncbi.nlm.nih.gov/29364890/